Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-13 22:51:34 ET
Precigen, Inc. (PGEN) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST
Company Participants
Steven Harasym - VP & Head of Investor Relations
Helen Sabzevari - President, CEO & Director
Phil Tennant - Chief Commercial Officer
Rutul Shah - Chief Operating Officer
Harry Thomasian - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript
Precigen Inc.
NASDAQ: PGEN
PGEN Trading
-3.91% G/L:
$3.42 Last:
304,188 Volume:
$3.43 Open:
PGEN Latest News
January 20, 2026 08:05:00 am
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
January 12, 2026 08:00:00 am
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026 04:05:00 pm
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
PGEN Stock Data
$1,632,900,063
187,173,160
1.3%
60
N/A
Biotechnology & Life Sciences
Healthcare
US
Germantown
